Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19. [electronic resource]
Producer: 20200528Description: 105967 p. digitalISSN:- 1872-7913
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.